Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn C Buse

Showing results (71-80 of 230) with videos related to

Pageof 23
Sort By:
Headache|November 1, 2018
When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent ChildrenElizabeth K Seng, Emily D Mauser, Maya Marzouk, et al.
Headache|February 17, 2021
Erenumab patient characteristics, medication adherence, and treatment patterns in the United StatesDionne M Hines, Shweta Shah, Jasjit K Multani, et al.
Headache|November 15, 2012
Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Dawn C Buse, Jane Saiers, et al.
Headache|January 23, 2016
Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention StudyVincent T Martin, Jelena Pavlovic, Kristina M Fanning, et al.
Neurology|December 26, 2014
Recalled maltreatment, migraine, and tension-type headache: results of the AMPP studyGretchen E Tietjen, Dawn C Buse, Kristina M Fanning, et al.
Health and Quality of Life Outcomes|October 8, 2016
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headachesSally Mannix, Anne Skalicky, Dawn C Buse, et al.
Frontiers in Neurology|June 22, 2026
Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention studyChristian Lampl, Richard B Lipton, Sarah Lipsius, et al.
Headache|August 10, 2021
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine-preventive medications in the phase 3b FOCUS studyEgilius L H Spierings, Xiaoping Ning, Verena Ramirez Campos, et al.
Headache|June 22, 2019
The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey StudyAmy A Gelfand, Dawn C Buse, Michael D Cabana, et al.
Headache|May 8, 2019
Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized TrialJames S McGinley, Dawn C Buse, Kenneth J Shulman, et al.
Pageof 23

Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
Headache|November 1, 2018
When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent ChildrenElizabeth K Seng, Emily D Mauser, Maya Marzouk, et al.
Headache|February 17, 2021
Erenumab patient characteristics, medication adherence, and treatment patterns in the United StatesDionne M Hines, Shweta Shah, Jasjit K Multani, et al.
Headache|November 15, 2012
Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Dawn C Buse, Jane Saiers, et al.
Headache|January 23, 2016
Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention StudyVincent T Martin, Jelena Pavlovic, Kristina M Fanning, et al.
Neurology|December 26, 2014
Recalled maltreatment, migraine, and tension-type headache: results of the AMPP studyGretchen E Tietjen, Dawn C Buse, Kristina M Fanning, et al.
Health and Quality of Life Outcomes|October 8, 2016
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headachesSally Mannix, Anne Skalicky, Dawn C Buse, et al.
Frontiers in Neurology|June 22, 2026
Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention studyChristian Lampl, Richard B Lipton, Sarah Lipsius, et al.
Headache|August 10, 2021
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine-preventive medications in the phase 3b FOCUS studyEgilius L H Spierings, Xiaoping Ning, Verena Ramirez Campos, et al.
Headache|June 22, 2019
The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey StudyAmy A Gelfand, Dawn C Buse, Michael D Cabana, et al.
Headache|May 8, 2019
Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized TrialJames S McGinley, Dawn C Buse, Kenneth J Shulman, et al.
Pageof 23